Llwytho...
Liquid biopsy and NSCLC
In the era of high-throughput molecular screening and personalized medicine, difficulty in determining whether cancer mutations are truly ‘actionable’ remains a gray zone in NSCLC. The most important prerequisite to perform such investigations is the tumor tissue retrieval via biopsy at diagnosis an...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | Lung Cancer Manag |
|---|---|
| Prif Awduron: | , , , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
Future Medicine Ltd
2016
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6310318/ https://ncbi.nlm.nih.gov/pubmed/30643553 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/lmt-2016-0006 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|